PROTALIX BIOTHERAPEUTICS INC
PLX·74365A309·US·Common Stock·Healthcare - Biotechnology-13D/G
PLX (PROTALIX BIOTHERAPEUTICS INC) is held by 64 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($7.8M), RENAISSANCE TECHNOLOGIES LLC ($2.7M), STATE STREET CORP ($2.1M). Net institutional sentiment: Mixed.
64
Holders
Avg rating(15 Elite)
$23.6M
Total Value
67% (68)
Fund Consensus
38 buying - 19 selling
Who's Trading
ActivistMAMAK Capital Fund LP4.5%Mar 30, 2026
InsiderBDBashan DrorBuy $101KDec 19, 2025
InsiderBABar-Shalev AmosSell $314.16Nov 18, 2025
InsiderSASchwartz AharonBuy $206KJun 10, 2025
13F: Insider & Congress:
Showing 1-20 of 68
1 / 4
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer